Life Sciences, MedTech and Digital Health

Our specialist lawyers provide full-service support throughout the entire product or service lifecycle to both established and early-stage organisations operating across the life sciences, MedTech and digital health sectors. 

Our clients include purchasers of digital health solutions, funders and investors, innovators of digital health and medical technology, pharmaceutical and biotech companies, medical device manufacturers, health app developers, and suppliers of electronic patient record systems. 

We advise at the forefront of the use of AI and technology in the sector, including advising purchasers, developers, and suppliers of ambient voice technology, robotics, clinical summarisation tools, and digital twin solutions on regulatory frameworks, safety standards, information governance, IP, and commercial transactions. Recognising the importance of collaboration between public bodies, industry, innovators, and scale-ups, we facilitate and support conversations to remove blockers to innovation and help bring new technologies and models of care to the sector. 

We support international clients with their expansion plans, whether that be overseas clients looking to sell into the UK for the first time or supporting clients entering new markets globally via a network of offices and associations across Europe, Asia-Pacific, Latin America, and North America. 

Our expertise includes advising on: 

• R&D, clinical trials, product approvals, and licensing
• Regulatory strategy, procurement, and market access 
• Protection, commercialisation, and enforcement of all aspects of intellectual property (including AI) 
• Commercialisation of health data, governance, cybersecurity, and data privacy 
• Commercial transactions, including customer contracts, joint ventures, revenue sharing agreements, value-based care contracting, clinical research contracts, and supply and distribution agreements 
• M&A, corporate joint ventures, stock exchange listings and fundings, as well as venture capital and private equity investment 
• Specialist regulatory due diligence on life sciences, MedTech and digital health transactions
• Pharmacovigilance, product safety, liability, and risk management, including handling claims, complaints, and recalls
• Advertising of medicines, medical devices, treatments, and health-related products 

Featured experience

• Advising a listed biotechnology company on material transfer and IP licensing, joint ventures and R&D agreements  
• Advising private equity and venture capital clients on regulatory due diligence projects in relation to life sciences, MedTech and digital health companies 
• Advising a national charity on a project to collect health data from a community  
• of 5 million volunteers – the world’s largest health research programme of its kind – to create a detailed picture of the nation’s health 
• Advising a MedTech manufacturer on the deployment and adoption of its AI-enabled product across the NHS, designed to risk stratify and prioritise patients for healthcare interventions 
• Advising a telemedicine provider on the online supply of weight loss medications, helping navigate the evolving regulatory landscape and the requirements of the MHRA Blue Guide  
• Advising on the establishment and AIM listing of a life sciences business and its associated fundraising